New look at PrEP study points to efficacy for transgender women

http://www.eurekalert.org/pub_releases/2015-11/uoc--nla110615.php

Eurekalert/University of California - San Francisco   11/06/2015

"In a new look at the groundbreaking iPrEx trial for people at high risk of HIV infection, UC San Francisco researchers have identified strong evidence of efficacy for transgender women when PrEP, a two-drug antiretroviral used to prevent HIV, is used consistently."